The Beauty Health Company (NASDAQ:SKIN) Stock Has Average Price Target of $18.00

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned an average rating of “Hold” from the eight analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $18.00.

A number of brokerages have recently issued reports on SKIN. Canaccord Genuity Group set a $11.00 price target on Beauty Health and gave the company a “hold” rating in a report on Thursday, October 22nd. TD Cowen reduced their price target on Beauty Health from $20.00 to $18.00 and set a “hold” rating for the company in a research report on Wednesday, August 12th. Citigroup restated a “hold” rating on shares of Beauty Health in a research note on Thursday, October 15th. Jefferies Financial Group restated a “hold” rating and set a $11.00 price objective (up from $0.85) on shares of Beauty Health in a research note on Monday, October 19th. Finally, Zacks Research downgraded Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th.

Beauty Health Price Performance

NASDAQ SKIN opened at $9.94 on Wednesday. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. The firm’s 50 day moving average price is $12.48 and its 200-day moving average price is $16.85. Beauty Health has a 52-week low of $9.68 and a 52-week high of $34.80. The company has a market cap of $64.68 million, a PE ratio of -2.26 and a beta of 1.05.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.50) by $0.10. The company had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. Sell-side analysts forecast that Beauty Health will post -3.18 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of SKIN. Bank of America Corp DE raised its stake in shares of Beauty Health by 19.2% during the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after acquiring an additional 17,088 shares in the last quarter. Renaissance Technologies LLC lifted its position in Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares during the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new stake in Beauty Health during the first quarter valued at approximately $17,270,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

About Beauty Health

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.